In addition, experimental studies have demonstrated that PlGF may serve both as a marker of adaptive cardiac remodeling and as a promising novel therapeutic agent for revascularizing and regenerating the infarcted myocardium and for improving its performance after MI [14;22]. This evidence concerns the gene PGF and myocardial infarction.